Avantor Inc. (NYSE:AVTR) Q3 2024 Earnings Conference Call October 25, 2024 8:00 AM ET
Company Participants
Christina Jones - VP, IR
Michael Stubblefield - President and Chief Executive Officer
Brent Jones - Executive Vice President and Chief Financial Officer
Conference Call Participants
Daniel Brennan - TD Cowen
Douglas Schenkel - Wolfe Research
Tycho Peterson - Jefferies
Michael Ryskin - Bank of America
Vijay Kumar - Evercore ISI
Daniel Leonard - UBS
Conor McNamara - RBC Capital Markets
Daniel Arias - Stifel
Rachel Vatnsdal - JP Morgan
Luke Sergott - Barclays
Tejas Savant - Morgan Stanley
Operator
Good morning. My name is Emily, and I will be your conference operator today. At this time, I would like to welcome everyone to Avantor's Third Quarter 2024 Earnings Results Conference Call. [Operator Instructions] I will now turn the call over to Christina Jones, Vice President of Investor Relations. Ms. Jones, you may begin the conference.
Christina Jones
Good morning. Thank you for joining us. Our speakers today are Michael Stubblefield, President and Chief Executive Officer; and Brent Jones, Executive Vice President and Chief Financial Officer. The press release and the presentation accompanying this call are available on our Investor Relations website at ir.avantorsciences.com. A replay of this webcast will also be made available on our website after the call. Following our prepared remarks, we will open the line for questions.
During this call, we will be making forward-looking statements within the meaning of the U.S. federal securities laws, including statements regarding events or developments that we believe or anticipate may occur in the future. These forward-looking statements are subject to a number of risks and uncertainties, including those set forth in our SEC filings. Actual results might differ materially from any forward-looking statements that we make today. These forward-looking statements speak only as of the date that they are made. We do not assume any obligation to update these forward-looking statements as a result of new information, future events or other developments. This call will include a discussion of non-GAAP measures. A reconciliation of these non-GAAP measures can be found in the press release and in the supplemental disclosure package on our Investor Relations website.
With that, I will now turn the call over to Michael.
Michael Stubblefield
Thank you, CJ, and good morning, everyone. I appreciate you joining us today. I'm starting on Slide 3. We delivered another solid quarter with in-line performance across all key financial metrics. Reported revenue increased sequentially to $1.71 billion, while organic revenue declined 0.7% year-over-year. We were encouraged by another quarter of outperformance in bioprocessing and as strong order rates continue as well as sequential and year-over-year growth in our Laboratory Solutions segment.